Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > This show DG has skin in the game

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 21, 2021 4:33pm

136 Views

Post# 32622573

This show DG has skin in the game

Participant Name	Roles
Amuka Capital Ltd	2018-02-22 Was disclosed as a finder for Co
Babaei Saeid	2015-11-30 Became a director of Co 2016-12-31 Was disclosed as holding an option on shares of Co 2017-03-15 Received shares for debt 2017-05-01 Was disclosed as a shareholder of Co 2018-07-23 Received shares for debt
Canaccord Genuity Corp	2018-02-22 Was disclosed as a finder for Co
Carmon Lior	2015-11-30 Became a director of Co 2017-05-01 Became a former director of Co
Chen Benjamin	2015-11-30 Became a director of Co 2017-12-05 Became a former director of Co
Chen Limor	2017-06-30 Was disclosed as an employee of Co 2017-12-05 Was disclosed as a former employee of Co
Echelon Wealth Partners Inc	2018-02-22 Was disclosed as a finder for Co
Emerge Resources Corp (2)	2016-03-10 Became a predecessor of Co
Gorecki Marian	2015-11-30 Became a director of Co 2017-05-01 Became a former director of Co
Goren David	2018-09-06 Became a director of Co 2021-01-18 Bought a private placement in Co 2021-01-18 Was disclosed as a shareholder of Co
Grayston Capital Investments Inc	2018-02-22 Was disclosed as a finder for Co
Kellen Ari	2017-12-05 Became a director of Co 2021-01-18 Bought a private placement in Co 2021-01-18 Was disclosed as a shareholder of Co
Langer Shawn	2017-12-05 Became a director of Co
Laredo Gregory	2018-02-22 Was disclosed as a finder for Co
Levin Gadi	2016-10-20 Became a director of Co 2017-03-15 Received shares for debt 2017-05-01 Was disclosed as a shareholder of Co 2018-07-23 Received shares for debt 2021-01-18 Bought a private placement in Co
M Partners Inc	2021-01-18 Was disclosed as a finder for Co
Maresky Isaac Benjamin	2015-11-30 Became a director of Co 2016-12-31 Was disclosed as holding an option on shares of Co 2017-05-01 Was disclosed as a shareholder of Co
Moyal Michelle	2021-01-18 Was disclosed as a finder for Co
Moyal Serge J	2018-02-22 Was disclosed as a finder for Co
Sunel Securities Inc	2017-03-15 Received shares for debt
Tommasi Mark Turner	2021-01-18 Was disclosed as a finder for Co
Vaal Capital Corp	2017-03-15 Received shares for debt 2018-07-23 Received shares for debt 2018-07-23 Was disclosed as a shareholder of Co